Published in J Cell Biol on March 29, 2010
The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function. Nat Rev Mol Cell Biol (2011) 4.24
p53 and its mutants in tumor cell migration and invasion. J Cell Biol (2011) 2.49
An invasive podosome-like structure promotes fusion pore formation during myoblast fusion. J Cell Biol (2010) 1.59
Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation. Arterioscler Thromb Vasc Biol (2011) 1.37
Vascular smooth muscle cell motility: From migration to invasion. Exp Clin Cardiol (2010) 1.33
Adhesion rings surround invadopodia and promote maturation. Biol Open (2012) 1.23
MicroRNA-638 is highly expressed in human vascular smooth muscle cells and inhibits PDGF-BB-induced cell proliferation and migration through targeting orphan nuclear receptor NOR1. Cardiovasc Res (2013) 1.21
A cell-based high-content screening assay reveals activators and inhibitors of cancer cell invasion. Sci Signal (2011) 1.20
Signaling inputs to invadopodia and podosomes. J Cell Sci (2013) 1.18
Can microRNAs control vascular smooth muscle phenotypic modulation and the response to injury? Physiol Genomics (2010) 1.16
Targeting invadopodia to block breast cancer metastasis. Oncotarget (2011) 1.10
Cell migration and invasion in human disease: the Tks adaptor proteins. Biochem Soc Trans (2012) 1.04
Rab40b regulates trafficking of MMP2 and MMP9 during invadopodia formation and invasion of breast cancer cells. J Cell Sci (2013) 1.04
The protein kinase C cascade regulates recruitment of matrix metalloprotease 9 to podosomes and its release and activation. Mol Cell Biol (2010) 1.03
Inorganic phosphate accelerates the migration of vascular smooth muscle cells: evidence for the involvement of miR-223. PLoS One (2012) 1.03
Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma. Oncogene (2011) 1.03
miR-424/322 regulates vascular smooth muscle cell phenotype and neointimal formation in the rat. Cardiovasc Res (2013) 0.99
miRNAs: roles and clinical applications in vascular disease. Expert Rev Mol Diagn (2011) 0.98
PDGF induced microRNA alterations in cancer cells. Nucleic Acids Res (2011) 0.97
Fascin1 promotes cell migration of mature dendritic cells. J Immunol (2011) 0.95
Signal transduction in the development of pulmonary arterial hypertension. Pulm Circ (2013) 0.95
MicroRNAs-control of essential genes: Implications for pulmonary vascular disease. Pulm Circ (2011) 0.94
A novel Rho-dependent pathway that drives interaction of fascin-1 with p-Lin-11/Isl-1/Mec-3 kinase (LIMK) 1/2 to promote fascin-1/actin binding and filopodia stability. BMC Biol (2012) 0.94
Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function. J Mol Cell Cardiol (2014) 0.91
Phosphorylation of G protein-coupled receptor kinase 2-interacting protein 1 tyrosine 392 is required for phospholipase C-gamma activation and podosome formation in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2010) 0.90
Importance of RhoGTPases in formation, characteristics, and functions of invadosomes. Small GTPases (2014) 0.90
microRNAs Distinctively Regulate Vascular Smooth Muscle and Endothelial Cells: Functional Implications in Angiogenesis, Atherosclerosis, and In-Stent Restenosis. Adv Exp Med Biol (2015) 0.89
Micromanaging abdominal aortic aneurysms. Int J Mol Sci (2013) 0.89
Podosomes in migrating microglia: components and matrix degradation. J Neuroinflammation (2012) 0.88
Non-coding RNAs: the "dark matter" of cardiovascular pathophysiology. Int J Mol Sci (2013) 0.87
The podosome marker protein Tks5 regulates macrophage invasive behavior. Cytoskeleton (Hoboken) (2011) 0.86
Fascin 1 is dispensable for developmental and tumour angiogenesis. Biol Open (2013) 0.86
Differential microRNA response to a high-cholesterol, high-fat diet in livers of low and high LDL-C baboons. BMC Genomics (2012) 0.86
Role of coronin 1B in PDGF-induced migration of vascular smooth muscle cells. Circ Res (2012) 0.85
MicroRNA-143/-145 in Cardiovascular Diseases. Biomed Res Int (2015) 0.83
Force Matters: Biomechanical Regulation of Cell Invasion and Migration in Disease. Trends Cell Biol (2016) 0.83
Toca-1 is suppressed by p53 to limit breast cancer cell invasion and tumor metastasis. Breast Cancer Res (2014) 0.83
Dendritic cell podosome dynamics does not depend on the F-actin regulator SWAP-70. PLoS One (2013) 0.82
MicroRNA Regulation of Smooth Muscle Phenotype. Mol Cell Pharmacol (2012) 0.82
p53 in cell invasion, podosomes, and invadopodia. Cell Adh Migr (2014) 0.82
Noncoding RNAs and atherosclerosis. Curr Atheroscler Rep (2014) 0.82
MicroRNA miR145 regulates TGFBR2 expression and matrix synthesis in vascular smooth muscle cells. Circ Res (2014) 0.82
p53 regulation of podosome formation and cellular invasion in vascular smooth muscle cells. Cell Adh Migr (2011) 0.82
Invadosomes in their natural habitat. Eur J Cell Biol (2014) 0.81
PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma. Hum Mol Genet (2012) 0.80
Podosome-regulating kinesin KIF1C translocates to the cell periphery in a CLASP-dependent manner. J Cell Sci (2014) 0.80
p53 Down regulates PDGF-induced formation of circular dorsal ruffles in rat aortic smooth muscle cells. PLoS One (2014) 0.80
Coupling between acto-adhesive machinery and ECM degradation in invadosomes. Cell Adh Migr (2014) 0.79
Therapeutic Potential of Modulating MicroRNA in Peripheral Artery Disease. Curr Vasc Pharmacol (2015) 0.78
Myocardin: new therapeutic agent in vascular disease? Arterioscler Thromb Vasc Biol (2013) 0.78
MicroRNA-141 inhibits vascular smooth muscle cell proliferation through targeting PAPP-A. Int J Clin Exp Pathol (2015) 0.78
ALK5 and ALK1 play antagonistic roles in transforming growth factor β-induced podosome formation in aortic endothelial cells. Mol Cell Biol (2014) 0.78
Smooth muscle specific overexpression of p22phox potentiates carotid artery wall thickening in response to injury. Oxid Med Cell Longev (2015) 0.77
Cell-cell fusion: a new function for invadosomes. Curr Biol (2011) 0.77
An overview of potential molecular mechanisms involved in VSMC phenotypic modulation. Histochem Cell Biol (2015) 0.76
Biophysical induction of vascular smooth muscle cell podosomes. PLoS One (2015) 0.76
Nicotine facilitates VSMC dysfunction through a miR-200b/RhoGDIA/cytoskeleton module. Sci Rep (2017) 0.75
Downregulation of microRNA‑34b is responsible for the elevation of blood pressure in spontaneously hypertensive rats. Mol Med Rep (2017) 0.75
MicroRNA-145 regulates platelet-derived growth factor-induced human aortic vascular smooth muscle cell proliferation and migration by targeting CD40. Am J Transl Res (2016) 0.75
Fascin, may the Forked be with you. Fly (Austin) (2014) 0.75
Therapeutic Potential of Modulating microRNAs in Atherosclerotic Vascular Disease. Curr Vasc Pharmacol (2013) 0.75
The physical interaction of p53 and plakoglobin is necessary for their synergistic inhibition of migration and invasion. Oncotarget (2016) 0.75
Silencing microRNA-143 protects the integrity of the blood-brain barrier: implications for methamphetamine abuse. Sci Rep (2016) 0.75
Epigenetics and Vascular Diseases: Influence of Non-coding RNAs and Their Clinical Implications. Front Cardiovasc Med (2017) 0.75
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
MicroRNAs modulate hematopoietic lineage differentiation. Science (2003) 30.05
MicroRNA gene expression deregulation in human breast cancer. Cancer Res (2005) 27.56
Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res (2003) 17.13
Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev (2004) 16.52
MicroRNA-133 controls cardiac hypertrophy. Nat Med (2007) 11.68
miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature (2009) 10.26
A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell (2005) 9.22
Role of platelet-derived growth factors in physiology and medicine. Genes Dev (2008) 8.89
Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev (1999) 8.36
Modulation of microRNA processing by p53. Nature (2009) 7.88
Regulation of differentiation of vascular smooth muscle cells. Physiol Rev (1995) 6.60
Src family kinases are required for integrin but not PDGFR signal transduction. EMBO J (1999) 5.05
Association between the PDGF receptor and members of the src family of tyrosine kinases. Cell (1990) 4.83
MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev (2009) 4.62
Podosomes: adhesion hot-spots of invasive cells. Trends Cell Biol (2003) 4.51
SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling. Mol Cell Biol (2000) 4.30
MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res (2009) 4.25
Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest (2009) 4.12
The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ (2009) 3.43
The interplay between Src family kinases and receptor tyrosine kinases. Oncogene (2004) 3.36
Assembly and biological role of podosomes and invadopodia. Curr Opin Cell Biol (2008) 3.26
Podosomes display actin turnover and dynamic self-organization in osteoclasts expressing actin-green fluorescent protein. Mol Biol Cell (2003) 3.11
Invadopodia: specialized cell structures for cancer invasion. Clin Exp Metastasis (2006) 3.05
The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells. Cancer Cell (2005) 2.91
Roles of fascin in cell adhesion and motility. Curr Opin Cell Biol (2004) 2.74
Downregulation of microRNAs-143 and -145 in B-cell malignancies. Cancer Sci (2007) 2.61
Isolation of vascular smooth muscle cells from a single murine aorta. Methods Cell Sci (2001) 2.48
Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proc Natl Acad Sci U S A (1988) 2.32
Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res (2007) 2.26
Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation (2009) 1.92
Biology of platelet-derived growth factor and its involvement in disease. Mayo Clin Proc (2006) 1.70
Active Rho is localized to podosomes induced by oncogenic Src and is required for their assembly and function. J Cell Biol (2004) 1.60
Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation. Mol Cell Biochem (1999) 1.51
Association of Fyn with the activated platelet-derived growth factor receptor: requirements for binding and phosphorylation. Oncogene (1992) 1.46
Conventional protein kinase C mediates phorbol-dibutyrate-induced cytoskeletal remodeling in a7r5 smooth muscle cells. Exp Cell Res (2002) 1.40
Protein kinase C family: on the crossroads of cell signaling in skin and tumor epithelium. J Cancer Res Clin Oncol (2007) 1.36
Protein kinase Calpha activates c-Src and induces podosome formation via AFAP-110. Mol Cell Biol (2004) 1.33
Calponin repeats regulate actin filament stability and formation of podosomes in smooth muscle cells. Mol Biol Cell (2003) 1.31
Smooth muscle specific expression of calponin. FEBS Lett (1990) 1.25
Differential translocation of protein kinase C isozymes by thrombin and platelet-derived growth factor. A possible function for phosphatidylcholine-derived diacylglycerol. J Biol Chem (1993) 1.22
p53 suppresses Src-induced podosome and rosette formation and cellular invasiveness through the upregulation of caldesmon. Mol Cell Biol (2009) 1.19
No requirement for src family kinases for PDGF signaling in fibroblasts expressing SV40 large T antigen. Oncogene (2000) 1.16
Formation of extracellular matrix-digesting invadopodia by primary aortic smooth muscle cells. Circ Res (2007) 1.07
Protein kinase C epsilon-Src modules direct signal transduction in nitric oxide-induced cardioprotection: complex formation as a means for cardioprotective signaling. Circ Res (2001) 1.06
MicroRNA-133 controls cardiac hypertrophy. Nat Med (2007) 11.68
Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell (2013) 4.99
The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev (2003) 4.47
The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function. Nat Rev Mol Cell Biol (2011) 4.24
The interplay between Src family kinases and receptor tyrosine kinases. Oncogene (2004) 3.36
ErbB2 is essential in the prevention of dilated cardiomyopathy. Nat Med (2002) 3.36
Assembly and biological role of podosomes and invadopodia. Curr Opin Cell Biol (2008) 3.26
The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells. Cancer Cell (2005) 2.91
MicroRNAs and cardiac pathology. Nat Rev Cardiol (2009) 2.50
Emerging role of microRNAs in cardiovascular biology. Circ Res (2007) 2.41
MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ Res (2009) 2.40
Association of the FOXO3A locus with extreme longevity in a southern Italian centenarian study. Rejuvenation Res (2009) 2.24
CaMK4 Gene Deletion Induces Hypertension. J Am Heart Assoc (2012) 2.14
Relation of various plasma growth factor levels in patients with stable angina pectoris and total occlusion of a coronary artery to the degree of coronary collaterals. Am J Cardiol (2005) 2.14
Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease. JACC Cardiovasc Interv (2013) 2.11
The adaptor protein fish associates with members of the ADAMs family and localizes to podosomes of Src-transformed cells. J Biol Chem (2003) 2.08
Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytes. Circ Res (2004) 2.08
MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. J Clin Invest (2010) 2.04
Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia. Circulation (2011) 1.99
Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation (2009) 1.92
IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation. Proc Natl Acad Sci U S A (2011) 1.87
MicroRNAs: components of an integrated system controlling cardiac development, physiology, and disease pathogenesis. Cardiovasc Res (2008) 1.75
MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat Cell Biol (2010) 1.74
Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res (2013) 1.72
The novel adaptor protein Tks4 (SH3PXD2B) is required for functional podosome formation. Mol Biol Cell (2009) 1.68
MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circ Res (2011) 1.67
A role for the podosome/invadopodia scaffold protein Tks5 in tumor growth in vivo. Eur J Cell Biol (2008) 1.65
Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina. Am Heart J (2006) 1.59
Tks5-dependent, nox-mediated generation of reactive oxygen species is necessary for invadopodia formation. Sci Signal (2009) 1.56
Rheb is a critical regulator of autophagy during myocardial ischemia: pathophysiological implications in obesity and metabolic syndrome. Circulation (2012) 1.56
MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/-mice. Thromb Haemost (2014) 1.53
Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine. Kidney Int (2005) 1.52
Nck adaptor proteins link Tks5 to invadopodia actin regulation and ECM degradation. J Cell Sci (2009) 1.51
Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy. J Cell Physiol (2008) 1.48
SOCS1 gene transfer accelerates the transition to heart failure through the inhibition of the gp130/JAK/STAT pathway. Cardiovasc Res (2012) 1.48
Mechanism of enhanced cardiac function in mice with hypertrophy induced by overexpressed Akt. J Biol Chem (2003) 1.47
TET2 and CSMD1 genes affect SBP response to hydrochlorothiazide in never-treated essential hypertensives. J Hypertens (2015) 1.43
Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail (2011) 1.40
The involvement of the tyrosine kinase c-Src in the regulation of reactive oxygen species generation mediated by NADPH oxidase-1. Mol Biol Cell (2008) 1.37
Physiological myocardial hypertrophy: how and why? Front Biosci (2008) 1.35
MicroRNA and cardiac pathologies. Physiol Genomics (2008) 1.32
Novel p47(phox)-related organizers regulate localized NADPH oxidase 1 (Nox1) activity. Sci Signal (2009) 1.29
Interval training normalizes cardiomyocyte function, diastolic Ca2+ control, and SR Ca2+ release synchronicity in a mouse model of diabetic cardiomyopathy. Circ Res (2009) 1.29
Akt regulates L-type Ca2+ channel activity by modulating Cavalpha1 protein stability. J Cell Biol (2009) 1.28
Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs. FASEB J (2004) 1.27
Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure. Cardiovasc Res (2008) 1.26
A cell-based high-content screening assay reveals activators and inhibitors of cancer cell invasion. Sci Signal (2011) 1.20
Circulating microRNAs and aerobic fitness--the HUNT-Study. PLoS One (2013) 1.20
MicroRNAs in cardiovascular biology and heart disease. Circ Cardiovasc Genet (2009) 1.19
Regulation of cell size and contractile function by AKT in cardiomyocytes. Ann N Y Acad Sci (2004) 1.19
Disruption of the podosome adaptor protein TKS4 (SH3PXD2B) causes the skeletal dysplasia, eye, and cardiac abnormalities of Frank-Ter Haar Syndrome. Am J Hum Genet (2010) 1.18
Induced pluripotent stem cell-derived cardiomyocytes in studies of inherited arrhythmias. J Clin Invest (2013) 1.17
Association study on long-living individuals from Southern Italy identifies rs10491334 in the CAMKIV gene that regulates survival proteins. Rejuvenation Res (2011) 1.17
A Src-Tks5 pathway is required for neural crest cell migration during embryonic development. PLoS One (2011) 1.16
Akt/protein kinase B and endothelial nitric oxide synthase mediate muscular neovascularization induced by tissue kallikrein gene transfer. Circulation (2004) 1.15
AKT participates in endothelial dysfunction in hypertension. Circulation (2004) 1.15
Myocardial sarcoplasmic reticulum Ca2+ ATPase function is increased by aerobic interval training. Eur J Cardiovasc Prev Rehabil (2008) 1.13
Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy. Proc Natl Acad Sci U S A (2013) 1.13
Anti-invasive adjuvant therapy with imipramine blue enhances chemotherapeutic efficacy against glioma. Sci Transl Med (2012) 1.12
Correlations between progression of coronary artery disease and circulating endothelial progenitor cells. FASEB J (2010) 1.10
Notch increases the shedding of HB-EGF by ADAM12 to potentiate invadopodia formation in hypoxia. J Cell Biol (2013) 1.10
Akt increases sarcoplasmic reticulum Ca2+ cycling by direct phosphorylation of phospholamban at Thr17. J Biol Chem (2009) 1.09
MicroRNAs control gene expression: importance for cardiac development and pathophysiology. Ann N Y Acad Sci (2008) 1.09
Heart infarct in NOD-SCID mice: therapeutic vasculogenesis by transplantation of human CD34+ cells and low dose CD34+KDR+ cells. FASEB J (2004) 1.09
Tks5 recruits AFAP-110, p190RhoGAP, and cortactin for podosome formation. Exp Cell Res (2009) 1.08
Aerobic interval training enhances cardiomyocyte contractility and Ca2+ cycling by phosphorylation of CaMKII and Thr-17 of phospholamban. J Mol Cell Cardiol (2007) 1.08
MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension. J Cell Physiol (2012) 1.07
Long noncoding RNA: a new player of heart failure? J Cardiovasc Transl Res (2013) 1.05
MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism. J Transl Med (2011) 1.01
Doubly heterozygous LMNA and TTN mutations revealed by exome sequencing in a severe form of dilated cardiomyopathy. Eur J Hum Genet (2013) 1.00
c-Myc oncoprotein: cell cycle-related events and new therapeutic challenges in cancer and cardiovascular diseases. Cell Cycle (2003) 1.00
Cardiotoxic effects, or lack thereof, of anti-ErbB2 immunoagents. FASEB J (2009) 0.95
Opposing roles of Akt and STAT3 in the protection of the maternal heart from peripartum stress. Cardiovasc Res (2014) 0.95
Effects of Akt on cardiac myocytes: location counts. Circ Res (2006) 0.94
Epigenetics: a new mechanism of regulation of heart failure? Basic Res Cardiol (2013) 0.94
Molecular determinants of the physiological adaptation to stress in the cardiomyocyte: a focus on AKT. J Mol Cell Cardiol (2004) 0.94
Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis. Proc Natl Acad Sci U S A (2002) 0.93
Fatty acid percentage in erythrocyte membranes of atrial flutter/fibrillation patients and controls. J Interv Card Electrophysiol (2010) 0.93
Circulating microRNAs as potential biomarkers of coronary artery disease: a promise to be fulfilled? Circ Res (2010) 0.93
microRNAs in hypertrophy and heart failure. Exp Biol Med (Maywood) (2011) 0.92
DNA and adenoviral vectors encoding carcinoembryonic antigen fused to immunoenhancing sequences augment antigen-specific immune response and confer tumor protection. Hum Gene Ther (2006) 0.92
Src-dependent Tks5 phosphorylation regulates invadopodia-associated invasion in prostate cancer cells. Prostate (2013) 0.92
Vectors encoding carcinoembryonic antigen fused to the B subunit of heat-labile enterotoxin elicit antigen-specific immune responses and antitumor effects. Vaccine (2007) 0.91
Stem cell therapy in heart diseases: a review of selected new perspectives, practical considerations and clinical applications. Curr Cardiol Rev (2011) 0.91
The multi-adaptor proto-oncoprotein Cbl is a key regulator of Rac and actin assembly. J Cell Sci (2003) 0.91
Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes. BMC Med Genet (2013) 0.90
Platelet-derived growth factor stimulates Src-dependent mRNA stabilization of specific early genes in fibroblasts. J Biol Chem (2005) 0.90
Role of microRNAs in haemopoiesis, heart hypertrophy and cancer. Biochem Soc Trans (2008) 0.89
MicroRNA-1 downregulation increases connexin 43 displacement and induces ventricular tachyarrhythmias in rodent hypertrophic hearts. PLoS One (2013) 0.89
RNA silencing: small RNA-mediated posttranscriptional regulation of mRNA and the implications for heart electropathophysiology. J Cardiovasc Electrophysiol (2008) 0.87
Cancer: Escape from inhibition. Nature (2003) 0.85
Podosomal proteins as causes of human syndromes: a role in craniofacial development? Genesis (2011) 0.85
Reliable resequencing of the human dystrophin locus by universal long polymerase chain reaction and massive pyrosequencing. Anal Biochem (2010) 0.85
Unexpectedly low mutation rates in beta-myosin heavy chain and cardiac myosin binding protein genes in Italian patients with hypertrophic cardiomyopathy. J Cell Physiol (2011) 0.85
Human embryonic stem cell-derived cardiomyocytes: inducing strategies. Regen Med (2006) 0.84
Arterial remodeling and atherosclerosis: miRNAs involvement. Vascul Pharmacol (2011) 0.83
p300/cAMP-response-element-binding-protein ('CREB')-binding protein (CBP) modulates co-operation between myocyte enhancer factor 2A (MEF2A) and thyroid hormone receptor-retinoid X receptor. Biochem J (2003) 0.83